Skip to content
naulon

Not checkedNot checked for notices yet.

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

Thitima Kongnakorn, Christian Eckmann, Matteo Bassetti and 4 more

Antimicrobial Resistance and Infection Control · 2019

doi:10.1186/s13756-019-0652-x (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.